Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 16, 2026 12:36 ET | Source: Hagens Berman Sobol Shapiro LLP

Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% – Hagens Berman

Investors who lost money in CORT after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
January 09, 2026 15:24 ET | Source: Hagens Berman Sobol Shapiro LLP

Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% – Hagens Berman

SAN FRANCISCO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) saw the price of their shares crater 50% on December 31, 2025 after the company...
January 07, 2026 17:58 ET | Source: Hagens Berman Sobol Shapiro LLP

Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% – Hagens Berman

Investors who lost money in CORT after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
September 28, 2021 08:00 ET | Source: Shareholders Foundation, Inc.

NASDAQ: CORT Investor Notice: Lawsuit against Corcept Therapeutics Incorporated Announced by Shareholders Foundation

SAN DIEGO, Sept. 28, 2021 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Corcept Therapeutics Incorporated (NASDAQ:...